|
1
|
Awad IA, Little JR, Akarawi WP and Ahl J:
Intracranial dural arteriovenous malformations: Factors
predisposing to an aggressive neurological course. J Neurosurg.
72:839–850. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chaudhary MY, Sachdev VP, Cho SH, Weitzner
I Jr, Puljic S and Huang YP: Dural arteriovenous malformation of
the major venous sinuses: An acquired lesion. AJNR Am J
Neuroradiol. 3:13–19. 1982.PubMed/NCBI
|
|
3
|
Kwon BJ, Han MH, Kang HS and Chang KH: MR
imaging findings of intracranial dural arteriovenous fistulas:
Relations with venous drainage patterns. AJNR Am J Neuroradiol.
26:2500–2507. 2005.PubMed/NCBI
|
|
4
|
Gandhi D, Chen J, Pearl M, Huang J,
Gemmete JJ and Kathuria S: Intracranial dural arteriovenous
fistulas: Classification, imaging findings, and treatment. AJNR Am
J Neuroradiol. 33:1007–1013. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chaudhary MY, Sachdev VP, Cho SH, Weitzner
I Jr, Puljic S and Huang YP: Dural arteriovenous malformation of
the major venous sinuses: An acquired lesion. AJNR Am J
Neuroradiol. 3:13–19. 1982.PubMed/NCBI
|
|
6
|
Cooper CJ, Said S, Nunez A, Quansah R,
Khalillullah S and Hernandez GT: Dural arteriovenous fistula
discovered in patient presenting with recent head trauma. Am J Case
Rep. 14:444–448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zaletel M, Surlan-Popovic K, Pretnar-Oblak
J and Zvan B: Moyamoya syndrome with arteriovenous dural fistula
after head trauma. Acta clinica Croatica. 50:115–120.
2011.PubMed/NCBI
|
|
8
|
Nabors MW, Azzam CJ, Albanna FJ, Gulya AJ,
Davis DO and Kobrine AI: Delayed postoperative dural arteriovenous
malformations. Report of two cases. J Neurosurg. 66:768–772. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yassari R, Jahromi B and Macdonald R:
Dural arteriovenous fistula after craniotomy for pilocytic
astrocytoma in a patient with protein S deficiency. Surg Neurol.
58:59–64. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barnwell SL, Halbach VV, Dowd CF,
Higashida RT, Hieshima GB and Wilson CB: A variant of arteriovenous
fistulas within the wall of dural sinuses. Results of combined
surgical and endovascular therapy. J Neurosurg. 74:199–204. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sakaki T, Morimoto T, Nakase H, Kakizaki T
and Nagata K: Dural arteriovenous fistula of the posterior fossa
developing after surgical occlusion of the sigmoid sinus. Report of
five cases. J Neurosurg. 84:113–118. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gross BA and Du R: The natural history of
cerebral dural arteriovenous fistulae. Neurosurgery. 71:594–603.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hanakita S, Koga T, Shin M, Shojima M,
Igaki H and Saito N: Role of Gamma Knife surgery in the treatment
of intracranial dural arteriovenous fistulas. J Neurosurg. 117
Suppl:S158–S163. 2012.
|
|
14
|
Chen L, Mao Y and Zhou LF: Local chronic
hypoperfusion secondary to sinus high pressure seems to be mainly
responsible for the formation of intracranial dural arteriovenous
fistula. Neurosurgery. 64:973–983. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Terada T, Higashida RT, Halbach VV, Dowd
CF, Tsuura M, Komai N, Wilson CB and Hieshima GB: Development of
acquired arteriovenous fistulas in rats due to venous hypertension.
J Neurosurg. 80:884–889. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Villeneuve NF, Lau A and Zhang DD:
Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin
proteasome system: An insight into cullin-ring ubiquitin ligases.
Antioxid Redox Signal. 13:1699–1712. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang M, An C, Gao Y, Leak RK, Chen J and
Zhang F: Emerging roles of Nrf2 and phase II antioxidant enzymes in
neuroprotection. Prog Neurobiol. 100:30–47. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bryan HK, Olayanju A, Goldring CE and Park
BK: The Nrf2 cell defence pathway: Keap1-dependent and -independent
mechanisms of regulation. Biochem Pharmacol. 85:705–717. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen G, Fang Q, Zhang J, Zhou D and Wang
Z: Role of the Nrf2-ARE pathway in early brain injury after
experimental subarachnoid hemorrhage. J Neurosci Res. 89:515–523.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Florczyk U, Jazwa A, Maleszewska M, Mendel
M, Szade K, Kozakowska M, Grochot-Przeczek A, Viscardi M, Czauderna
S, Bukowska-Strakova K, et al: Nrf2 regulates angiogenesis: Effect
on endothelial cells, bone marrow-derived proangiogenic cells and
hind limb ischemia. Antioxid Redox Signal. 20:1693–1708. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ji X, Wang H, Zhu J, Zhu L, Pan H, Li W,
Zhou Y, Cong Z, Yan F and Chen S: Knockdown of Nrf2 suppresses
glioblastoma angiogenesis by inhibiting hypoxia-induced activation
of HIF-1α. Int J Cancer. 135:574–584. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ji XJ, Chen SH, Zhu L, Pan H, Zhou Y, Li
W, You WC, Gao CC, Zhu JH, Jiang K and Wang HD: Knockdown of
NF-E2-related factor 2 inhibits the proliferation and growth of
U251MG human glioma cells in a mouse xenograft model. Oncol Rep.
30:157–164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim TH, Hur EG, Kang SJ, Kim JA, Thapa D,
Lee YM, Ku SK, Jung Y and Kwak MK: NRF2 blockade suppresses colon
tumor angiogenesis by inhibiting hypoxia-induced activation of
HIF-1α. Cancer Res. 71:2260–2275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shin Y, Nakase H, Nakamura M, Shimada K,
Konishi N and Sakaki T: Expression of angiogenic growth factor in
the rat DAVF model. Neurol Res. 29:727–733. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang JW, Wang HD, Zhong WZ, Li N and Cong
ZX: Expression and cell distribution of metabotropic glutamate
receptor 5 in the rat cortex following traumatic brain injury.
Brain Res. 1464:73–81. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu J, Wang H, Ding K, Lu X, Li T and Wang
J, Wang C and Wang J: Inhibition of cathepsin S produces
neuroprotective effects after traumatic brain injury in mice.
Mediators Inflamm. 2013:1878732013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bederson JB, Wiestler OD, Brüstle O, Roth
P, Frick R and Yasargil MG: Intracranial venous hypertension and
the effects of venous outflow obstruction in a rat model of
arteriovenous fistula. Neurosurgery. 29:341–350. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kojima T, Miyachi S, Sahara Y, Nakai K,
Okamoto T, Hattori K, Kobayashi N, Hattori K, Negoro M and Yoshida
J: The relationship between venous hypertension and expression of
vascular endothelial growth factor: Hemodynamic and
immunohistochemical examinations in a rat venous hypertension
model. Surg Neurol. 68:277–284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang ST, Rodriguez-Hernandez A, Walker EJ,
Young WL, Su H and Lawton MT: Adult mouse venous hypertension
model: Common carotid artery to external jugular vein anastomosis.
J Vis Exp. 27:504722015.
|
|
31
|
Zou X, Zhou L, Zhu W, Mao Y and Chen L:
Effectiveness of 2-methoxyestradiol in alleviating angiogenesis
induced by intracranial venous hypertension. J Neurosurg.
125:746–753. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lawton MT, Jacobowitz R and Spetzler RF:
Redefined role of angiogenesis in the pathogenesis of dural
arteriovenous malformations. J Neurosurg. 87:267–274. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu Y, Lawton MT, Du R, Shwe Y, Chen Y,
Shen F, Young WL and Yang GY: Expression of hypoxia-inducible
factor-1 and vascular endothelial growth factor in response to
venous hypertension. Neurosurgery. 59:687–696. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hayashi T, Abe K, Suzuki H and Itoyama Y:
Rapid induction of vascular endothelial growth factor gene
expression after transient middle cerebral artery occlusion in
rats. Stroke. 28:2039–2044. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tirakotai W, Bertalanffy H, Liu-Guan B,
Farhoud A and Sure U: Immunohistochemical study in dural
arteriovenous fistulas and possible role of local hypoxia for the
de novo formation of dural arteriovenous fistulas. Clin Neurol
Neurosurg. 107:455–460. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kweider N, Fragoulis A, Rosen C, Pecks U,
Rath W, Pufe T and Wruck CJ: Interplay between vascular endothelial
growth factor (VEGF) and nuclear factor erythroid 2-related
factor-2 (Nrf2): Implications for preeclampsia. The Journal of
biological chemistry. 286:42863–42872. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Q, Zhang Q, Huang QH, Fang YB, Zhang
ZL, Xu Y and Liu JM: A pivotal role of the vascular endothelial
growth factor signaling pathway in the formation of venous
hypertension-induced dural arteriovenous fistulas. Mol Med Rep.
9:1551–1558. 2014.PubMed/NCBI
|
|
38
|
Lee JM and Johnson JA: An important role
of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem
Mol Biol. 37:139–143. 2004.PubMed/NCBI
|
|
39
|
Itoh K, Wakabayashi N, Katoh Y, Ishii T,
Igarashi K, Engel JD and Yamamoto M: Keap1 represses nuclear
activation of antioxidant responsive elements by Nrf2 through
binding to the amino-terminal Neh2 domain. Genes Dev. 13:76–86.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kensler TW, Wakabayashi N and Biswal S:
Cell survival responses to environmental stresses via the
Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 47:89–116.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nguyen T, Nioi P and Pickett CB: The
Nrf2-antioxidant response element signaling pathway and its
activation by oxidative stress. J Biol Chem. 284:13291–13295. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Uno K, Prow TW, Bhutto IA, Yerrapureddy A,
McLeod DS, Yamamoto M, Reddy SP and Lutty GA: Role of Nrf2 in
retinal vascular development and the vaso-obliterative phase of
oxygen-induced retinopathy. Exp Res. 90:493–500. 2010.
|
